Hyphema Post Intravitreal Injection of Bevacizumab
Lucrèce Joanelle Vydalie Eriga *
Department of Ophthalmology, Hôpital Militaire D’instruction Mohammed V, Rabat, Morocco.
Arnaud Hugues Yempabou Yonli
Department of Ophthalmology, Hôpital Militaire D’instruction Mohammed V, Rabat, Morocco.
Ricardo Mendes
Department of Ophthalmology, Hôpital Militaire D’instruction Mohammed V, Rabat, Morocco.
Yassine Mouzari
Department of Ophthalmology, Hôpital Militaire D’instruction Mohammed V, Rabat, Morocco.
Abdelbarre Oubaaz
Department of Ophthalmology, Hôpital Militaire D’instruction Mohammed V, Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Objective: To describe a case of total hyphema after intravitreal injection of Bevacizumab.
Results: This is a 54 years old patient diagnosed with exudative age-related macular degeneration who was admitted for injection of Bevacizumab in the right eye. The visual acuity was 02/10 in both eyes, and the injection was performed after eliminating the contraindications on biomicroscope examination. The immediate evolution after injection was marked by a total hyphema. The management was based on antibiotic and anti-inflammatory eye drops, rehydration and monitoring. The hyphema disappeared after ten days with visual acuity remained at 02/10.
Keywords: Hyphema, bevacizumab, exudative, macular